EU, Canada, others push trade plan to help in COVID-19 battle

Published 24/11/2020, 04:30 am

By Philip Blenkinsop

BRUSSELS, Nov 23 (Reuters) - The European Union, Canada and 11 other countries agreed on Monday to measures such as eliminating export curbs they believe should form the basis of a global deal to help tackle COVID-19 and future pandemics.

The "Ottawa Group" will present its proposals to the World Trade Organization in mid-December in the hope its 164 members will sign up early in 2021.

"If we adopt something in early spring of next year, say March, that would still be a moment when this would be relevant for the management of the pandemic," a European Commission official said, adding this would cover a busy period when vaccines were being made and distributed.

The group, which does not include the United States or China, wants WTO members to commit to removing export restrictions on medical supplies - some 70 still have them in place, according to EU officials.

Any such restrictions should be targeted and temporary and not disturb the COVAX initiative to provide equitable access to COVID-19 drugs.

WTO members should, they say, take steps to ease trade flows, such as streamlining customs, and not impose on pandemic-related goods during the crisis.

They also urge greater transparency and believe the WTO, World Health Organization and World Customs Organization can work more closely to be ready for future pandemics.

The Ottawa Group's other members are Australia, Brazil, Chile, Japan, Kenya, South Korea, Mexico, New Zealand, Norway, Singapore and Switzerland.

The group's initiative is not the only one related to the pandemic at the WTO.

India, South Africa and other developing countries want to waive intellectual property rules to improve access to affordable drugs. European Union, the United States and other wealthy nations oppose this, saying pharmaceutical companies need financial incentives to develop vaccines and therapies and there is sufficient flexibility under existing trade rules.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.